DOI:
10.1055/s-00000031
Klinische Monatsblätter für Augenheilkunde
LinksClose Window
References
Kahaly GJ, Riedl M, Konig J. et al.
Mycophenolate plus methylprednisolone versus methylprednisolone alone in active, moderate-to-severe Gravesʼ orbitopathy (MINGO): a randomised, observer-masked, multicentre trial.
Lancet Diabetes Endocrinol 2018;
6: 287-298
doi:10.1016/S2213-8587(18)30020-2
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.